Neurocrine to slash workforce
From Times Wire Services
Neurocrine Biosciences Inc. said it would fire 130 employees, or more than half its workforce, to cut costs after its insomnia drug failed to win U.S. approval, leaving the company with no product to sell.
The San Diego company will have about 120 employees after the cutbacks, Neurocrine said.
